Deodorants: Do we really need them?

 

Bristol, UK (January 17, 2013) – New research shows that more than 75 per cent of people with a particular version of a gene don’t produce under-arm odour but use deodorant anyway. The study was based on a sample of 6,495 women who are part of the wider Children of the 90s study at the University of Bristol. The researchers found that about two per cent (117 out of 6,495) of mothers carry a rare version of a particular gene (ABCC11), which means they don’t produce any under-arm odour.

 

While about 5 per cent of people who produce an odour do not use deodorant, more than a fifth (26 out of 117) of those who don’t produce an odour do not use deodorant, a statistically highly significant difference. However, 78 per cent of people who do not produce odour, still use deodorant on all or most days.

 

Speaking about the novel finding, published today in the Journal of Investigative Dermatology, the lead author Professor Ian Day said:

 

‚An important finding of this study relates to those individuals who, according to their genotype, do not produce under-arm odour. One quarter of these individuals must consciously or subconsciously recognise that they do not produce odour and do not use deodorant, whereas most odour producers do use deodorant. However, three quarters of those who do not produce an odour regularly use deodorants; we believe that these people simply follow socio-cultural norms. This contrasts with the situation in North East Asia, where most people do not need to use deodorant and they don’t.‘

 

The first author of the paper, Dr Santiago Rodriguez added:

 

‚These findings have some potential for using genetics in the choice of personal hygiene products. A simple gene test might strengthen self-awareness and save some unnecessary purchases and chemical exposures for non-odour producers.‘

 

The authors highlight that people who carry this rare genetic variant are also more likely to have dry (rather than sticky) ear wax and that checking ear wax is a good indicator of whether or not a person produces under-arm odour.

 

Previous studies have shown that there is a link between a genetic variant located in the ABCC11 gene and under-arm odour. Sweat glands produce sweat which, combined with bacteria, result in under-arm odour. The production of odour depends on the existence of an active ABCC11 gene. However, the ABCC11 gene is known to be inactive in some people.

 

This study looked for the first time at deodorant usage in relation to ABCC11 genotype and also in comparison with other factors such as age, background and general household hygiene. At the individual level, the influence of ABCC11 genotype was much stronger than the other factors. The statistical support for the ABCC11 finding was extremely strong – the random chance of getting the same answer was less than one in a million million million odds.

 

 

Notes to editors

 

1. The paper: ‚Dependence of deodorant usage on ABCC11 genotype: scope for personalised genetics in personal hygiene‘ by Santiago Rodriguez et al is published today [17 January 2013] in the Journal of Investigative Dermatology, (Nature Publishing), doi:10.1038/jid.2012.480

 

2. According to Euromonitor, the retail sales value of the deodorant industry was £604m in 2011, representing a potential saving of over £12m to the 2 per cent of UK adults who don’t produce under-arm odour if they dispensed with deodorants.

 

 


 

University of Bristol, 17.01.2013 (tB).

MEDICAL NEWS

IU School of Medicine researchers develop blood test for anxiety
COVID-19 pandemic increased rates and severity of depression, whether people…
COVID-19: Bacterial co-infection is a major risk factor for death,…
Regenstrief-led study shows enhanced spiritual care improves well-being of ICU…
Hidden bacteria presents a substantial risk of antimicrobial resistance in…

SCHMERZ PAINCARE

Hydromorphon Aristo® long ist das führende Präferenzpräparat bei Tumorschmerz
Sorgen und Versorgen – Schmerzmedizin konkret: „Sorge als identitätsstiftendes Element…
Problem Schmerzmittelkonsum
Post-Covid und Muskelschmerz
Kopfschmerz bei Übergebrauch von Schmerz- oder Migränemitteln

DIABETES

Wie das Dexom G7 abstrakte Zahlen mit Farben greifbar macht…
Diabetes mellitus: eine der großen Volkskrankheiten im Blickpunkt der Schmerzmedizin
Suliqua®: Einfacher hin zu einer guten glykämischen Kontrolle
Menschen mit Diabetes während der Corona-Pandemie unterversorgt? Studie zeigt auffällige…
Suliqua® zur Therapieoptimierung bei unzureichender BOT

ERNÄHRUNG

Positiver Effekt der grünen Mittelmeerdiät auf die Aorta
Natriumaufnahme und Herz-Kreislaufrisiko
Tierwohl-Fleisch aus Deutschland nur mäßig attraktiv in anderen Ländern
Diät: Gehirn verstärkt Signal an Hungersynapsen
Süßigkeiten verändern unser Gehirn

ONKOLOGIE

Strahlentherapie ist oft ebenso effizient wie die OP: Neues vom…
Zanubrutinib bei chronischer lymphatischer Leukämie: Zusatznutzen für bestimmte Betroffene
Eileiter-Entfernung als Vorbeugung gegen Eierstockkrebs akzeptiert
Antibiotika als Störfaktor bei CAR-T-Zell-Therapie
Bauchspeicheldrüsenkrebs: Spezielle Diät kann Erfolg der Chemotherapie beeinflussen

MULTIPLE SKLEROSE

Multiple Sklerose: Aktuelle Immunmodulatoren im Vergleich
Neuer Biomarker für Verlauf von Multipler Sklerose
Multiple Sklerose: Analysen aus Münster erhärten Verdacht gegen das Epstein-Barr-Virus
Aktuelle Daten zu Novartis Ofatumumab und Siponimod bestätigen Vorteil des…
Multiple Sklerose durch das Epstein-Barr-Virus – kommt die MS-Impfung?

PARKINSON

Meilenstein in der Parkinson-Forschung: Neuer Alpha-Synuclein-Test entdeckt die Nervenerkrankung vor…
Neue Erkenntnisse für die Parkinson-Therapie
Cochrane Review: Bewegung hilft, die Schwere von Bewegungssymptomen bei Parkinson…
Technische Innovationen für eine maßgeschneiderte Parkinson-Diagnostik und Therapie
Biomarker und Gene: neue Chancen und Herausforderungen für die Parkinson-Diagnose…